ArticleMedical & biological engineering & computing2022
Extended Kalman filter state estimation-based nonlinear explicit model predictive control design for blood glucose regulation of type 1 diabetic patient.
Article in Medical & biological engineering & computing, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Automated blood glucose regulation for nonlinear model of type-1 diabetic patient under uncertainties: GWOCS type-2 fuzzy approach.Biomedical engineering letters · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The computational burden of iterative online optimization-based model predictive control (MPC) process is solved by adapting off-line optimization-based nonlinear explicit model predictive control (NEMPC). In this paper, the application of NEMPC is verified to regulate blood glucose level in type 1 diabetes mellitus (T1DM) patients. The objective of glucose regulation is to avoid hyperglycemia (> 180 mg/dl) and hypoglycemia (< 50 mg/dl) by maintaining glucose level in the range of 70 to 180 mg/dl. It helps to avoid time complexity of iterative process during solution of optimization stage in MPC. In the nonlinear T1DM model, only the state dynamic of sugar is measurable with low complexity and high cost among other states of the model. Therefore, an extended Kalman filter (EKF) is used developed to estimate unavailable states. The information of the estimated states are used to develop the proposed control approach for the T1DM patients. The simulation results of the NEMPC along with EKF-based state estimator for T1DM model shows the regulation of blood glucose-level (BGL) within 70 to 180 mg/dl within 120 min. The robustness of the proposed scheme is also verified under the change in parameters and food disturbance. The control variability grid analysis (CVGA) of NEMPC for 50 numbers of virtual T1DM patients under random parametric changes and meal disturbances shows the avoidance of hypoglycemia and hyperglycemia in type 1 diabetic patients. The proposed control method is simple, robust and efficient to regulate glucose level in T1DM patients. Extended Kalman filter state estimator based nonlinear explicit model predictive control for blood glucose regulation in Type 1 diabetic patients.
Indexed as
Identifiers
35274280What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.